MEN2: Medullary Thyroid Cancer and the Parathyroids
Written by John P. Sabra, MD FACS
Updated September 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
Multiple Endocrine Neoplasia type 2 (MEN2) is an inherited syndrome caused by mutations in the RET proto-oncogene. It predisposes affected patients to medullary thyroid cancer (essentially always), pheochromocytoma (often), and primary hyperparathyroidism (in some forms). Our genetic understanding of MEN2 has transformed how these patients are managed, particularly the use of prophylactic thyroidectomy in children identified through genetic testing.
MEN2 has two main forms, separated by which tumors occur and how they behave.
MEN2A: The more common form. Medullary thyroid cancer in essentially all patients. Pheochromocytoma in approximately 50%. Primary hyperparathyroidism in 20 to 30%. Affected patients typically present in the third or fourth decade.
MEN2B: Less common but more aggressive. Medullary thyroid cancer often develops in childhood. Pheochromocytoma occurs in about 50%. Characteristic physical features include mucosal neuromas (small bumps on the tongue and lips), a marfanoid body habitus, and gastrointestinal abnormalities. Primary hyperparathyroidism is uncommon in MEN2B.
Familial medullary thyroid cancer (FMTC): A milder form in which medullary cancer occurs without the other features. Some experts consider this a variant of MEN2A.
The Genetic Foundation
MEN2 is caused by activating mutations in the RET proto-oncogene. The specific mutation predicts the clinical course: some mutations go along with more aggressive medullary cancer, others with milder disease, and some with specific features such as the early MEN2B phenotype. These genotype-phenotype correlations are well-established and guide the timing of prophylactic thyroidectomy.
⚕ Clinical note
RET mutation testing should be performed for every patient diagnosed with medullary thyroid cancer, even when there is no family history. Approximately 5 to 7% of apparently sporadic medullary cancers turn out to carry a RET mutation, which identifies the patient and their family as MEN2 cases. The result has implications for both the patient and first-degree relatives.
Prophylactic Thyroidectomy in Children
One of the most important changes in MEN2 management over the past 30 years is the use of prophylactic total thyroidectomy in children identified by genetic testing. Because medullary thyroid cancer is essentially universal in RET mutation carriers and becomes more aggressive with time, removing the thyroid before cancer develops, or while it remains microscopic, produces excellent long-term outcomes.
| RET Mutation Risk Level | Recommended Timing of Prophylactic Thyroidectomy |
|---|---|
| Highest risk (MEN2B mutations) | First year of life if possible. |
| High risk | Before age 5. |
| Moderate risk | Before age 10 or when calcitonin begins to rise. |
Pheochromocytoma Screening
Pheochromocytoma is a tumor of the adrenal gland that produces excess catecholamines (adrenaline-like hormones). In MEN2 patients, it can cause hypertension, palpitations, and life-threatening blood pressure crises, particularly during anesthesia. Screening with plasma or urine metanephrines is performed annually in adult MEN2 patients starting at adolescence. Any thyroid or parathyroid surgery in a MEN2 patient must be preceded by pheochromocytoma screening.
Parathyroid Disease in MEN2
Primary hyperparathyroidism in MEN2A is generally milder than in MEN1. It often presents in the third or fourth decade and is more often single-gland or limited-gland disease rather than the four-gland involvement typical of MEN1. The surgical approach can therefore be more conservative: removal of clearly enlarged glands, with the others left alone unless they are also abnormal.
When parathyroid surgery is needed in a MEN2 patient, it is often performed at the same time as thyroidectomy when both are indicated. The glands sit close together, so combined surgery is practical and the surgical exposure is similar.
⚕ Clinical note
MEN2 should be managed by a multidisciplinary team experienced specifically with the syndrome. That includes endocrine surgery, endocrinology, genetics, and often pediatric endocrinology when children are involved. The complexity of long-term surveillance and the importance of coordinated decision-making make specialty-center care substantially better than fragmented community management.
Family Implications
MEN2 is inherited in an autosomal dominant pattern, meaning each child of an affected parent has a 50% chance of carrying the mutation. Genetic testing for first-degree relatives is essential. Family members who test positive can begin appropriate surveillance and consider prophylactic thyroidectomy. Family members who test negative are spared a lifetime of surveillance for a syndrome they do not carry.
The Bottom Line
MEN2 is an inherited syndrome with medullary thyroid cancer, pheochromocytoma, and (in MEN2A) primary hyperparathyroidism. Genetic testing identifies affected family members, including young children who benefit from prophylactic thyroidectomy. Lifelong surveillance for all three tumor types is essential. Multidisciplinary care at a center experienced with the syndrome substantially improves outcomes.
If you or a family member has been diagnosed with MEN2 or carries a RET mutation, seek care at an endocrine center with established experience in the syndrome and make sure all first-degree relatives are offered genetic testing.
This article is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances and clinical judgment determine the appropriate evaluation and management for every patient.
More from the Parathyroid Disease series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →